Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Corbus Pharma (CRBP)

Corbus Pharma (CRBP)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 130,240
  • Shares Outstanding, K 125,231
  • Annual Sales, $ 3,940 K
  • Annual Income, $ -111,270 K
  • 60-Month Beta 1.81
  • Price/Sales 34.99
  • Price/Cash Flow N/A
  • Price/Book 2.03
Trade CRBP with:

Options Overview Details

View History
  • Implied Volatility 99.83%
  • Historical Volatility 66.88%
  • IV Percentile 12%
  • IV Rank 18.66%
  • IV High 241.79% on 10/02/20
  • IV Low 67.27% on 07/21/21
  • Put/Call Vol Ratio 0.01
  • Today's Volume 2,443
  • Volume Avg (30-Day) 786
  • Put/Call OI Ratio 0.10
  • Today's Open Interest 24,298
  • Open Int (30-Day) 20,739

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/21
See More
  • Average Estimate -0.12
  • Number of Estimates 4
  • High Estimate -0.09
  • Low Estimate -0.13
  • Prior Year -0.43
  • Growth Rate Est. (year over year) +72.09%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.9805 +6.07%
on 09/21/21
1.3200 -21.21%
on 09/03/21
-0.2400 (-18.75%)
since 08/24/21
3-Month
0.9805 +6.07%
on 09/21/21
1.9700 -47.21%
on 06/28/21
-1.0300 (-49.76%)
since 06/24/21
52-Week
0.9100 +14.29%
on 10/30/20
4.0000 -74.00%
on 02/11/21
-0.5000 (-32.47%)
since 09/24/20

Most Recent Stories

More News
Corbus Pharmaceuticals (CRBP) Reports Q2 Loss, Lags Revenue Estimates

Corbus Pharmaceuticals (CRBP) delivered earnings and revenue surprises of -25.00% and -83.57%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?...

CRBP : 1.0400 (-5.45%)
Corbus Pharmaceuticals: Q2 Earnings Snapshot

NORWOOD, Mass. (AP) _ Corbus Pharmaceuticals Holdings Inc. (CRBP) on Thursday reported a loss of $17.1 million in its second quarter.

CRBP : 1.0400 (-5.45%)
Corbus Pharmaceuticals Reports Second Quarter 2021 Financial Results and Provides Corporate Updates

Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) ("Corbus" or the "Company"), an immunology company, today provided corporate updates and reported financial results for the second quarter of 2021.

CRBP : 1.0400 (-5.45%)
Thinking about buying stock in Aravive, Marin Software, Staffing 360 Solutions, Corbus Pharmaceuticals, or Globalstar?

/PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for ARAV, MRIN, STAF, CRBP, and GSAT.

GSAT : 1.6800 (-5.62%)
STAF : 2.07 (-3.72%)
ARAV : 4.02 (-1.71%)
CRBP : 1.0400 (-5.45%)
MRIN : 10.21 (+19.56%)
Corbus Pharmaceuticals Announces Topline Results from DETERMINE Phase 3 Study of Lenabasum for Treatment of Dermatomyositis

Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) ("Corbus" or the "Company"), an immunology company developing innovative medicines that target inflammation, fibrosis, metabolism and immuno-oncology,...

CRBP : 1.0400 (-5.45%)
Are Options Traders Betting on a Big Move in Corbus Pharmaceuticals (CRBP) Stock?

Investors need to pay close attention to Corbus Pharmaceuticals (CRBP) stock based on the movements in the options market lately.

CRBP : 1.0400 (-5.45%)
Thinking about buying stock in AMC, Corbus Pharmaceuticals, Syros Pharmaceuticals, Canaan, or Lineage Cell Therapeutics?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for AMC, CRBP, SYRS, CAN, and LCTX.

LCTX : 2.57 (-2.65%)
CAN : 6.11 (-21.16%)
CRBP : 1.0400 (-5.45%)
SYRS : 4.77 (+1.06%)
AMC : 40.01 (+0.08%)
Corbus Pharmaceuticals Licenses Two Integrin Targeting mAbs Further Expanding Pipeline into Cancer and Fibrotic Diseases

-- Corbus diversifies pipeline with two new mAbs that target integrins that inhibit activation of TGFB

CRBP : 1.0400 (-5.45%)
Corbus Pharmaceuticals Announces Publication of Two Abstracts at EULAR 2021 Virtual Congress

Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) ("Corbus" or the "Company"), a clinical-stage drug development company pioneering transformative medicines that target the endocannabinoid system, today...

CRBP : 1.0400 (-5.45%)
CORBUS PHARMACEUTICALS ANNOUNCES ADJOURNMENT OF ANNUAL MEETING

Corbus PharmaceuticalsHoldings, Inc. (NASDAQ: CRBP) ("Corbus" or the "Company"), a clinical-stage drug development company pioneering transformative medicines that target the endocannabinoid system, today...

CRBP : 1.0400 (-5.45%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Corbus Pharmaceuticals Holdings, Inc. is a Phase 3 clinical-stage pharmaceutical company focused on the development and commercialization of novel therapeutics to treat rare, chronic, and serious inflammatory and fibrotic diseases. The Company's lead product candidate, lenabasum, is a novel, synthetic...

See More

Key Turning Points

3rd Resistance Point 1.1333
2nd Resistance Point 1.1067
1st Resistance Point 1.0733
Last Price 1.0400
1st Support Level 1.0133
2nd Support Level 0.9867
3rd Support Level 0.9533

See More

52-Week High 4.0000
Fibonacci 61.8% 2.8196
Fibonacci 50% 2.4550
Fibonacci 38.2% 2.0904
Last Price 1.0400
52-Week Low 0.9100

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar